Cargando…

Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials

Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitzer, Ernest, Hahn, Rebecca T, Pibarot, Philippe, de Vries, Ton, Bax, Jeroen J, Leon, Martin B, Van Mieghem, Nicolas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545996/
https://www.ncbi.nlm.nih.gov/pubmed/31179020
http://dx.doi.org/10.15420/cfr.2018.41.2
_version_ 1783423481526878208
author Spitzer, Ernest
Hahn, Rebecca T
Pibarot, Philippe
de Vries, Ton
Bax, Jeroen J
Leon, Martin B
Van Mieghem, Nicolas M
author_facet Spitzer, Ernest
Hahn, Rebecca T
Pibarot, Philippe
de Vries, Ton
Bax, Jeroen J
Leon, Martin B
Van Mieghem, Nicolas M
author_sort Spitzer, Ernest
collection PubMed
description Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event.
format Online
Article
Text
id pubmed-6545996
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-65459962019-06-07 Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials Spitzer, Ernest Hahn, Rebecca T Pibarot, Philippe de Vries, Ton Bax, Jeroen J Leon, Martin B Van Mieghem, Nicolas M Card Fail Rev Co-Morbidities Aortic stenosis is a progressive disease that develops over decades, and once symptomatic and untreated, is associated with poor survival. Transcatheter aortic valve replacement has evolved significantly in the past decade and has expanded its indication from surgically inoperable and high-risk patients to patients with intermediate risk. Assessment of heart failure-related outcomes include the use of functional assessments, disease-specific quality of life surveys and standardised ascertainment of events, such as hospitalisations. Multiple statistical approaches are currently being tested to account for recurrent events such as hospitalisations for heart failure or to combine binary and continuous outcomes, both intended to assess the holistic burden of the disease, as opposed to the traditional analysis of time to first event. Radcliffe Cardiology 2019-05-24 /pmc/articles/PMC6545996/ /pubmed/31179020 http://dx.doi.org/10.15420/cfr.2018.41.2 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Co-Morbidities
Spitzer, Ernest
Hahn, Rebecca T
Pibarot, Philippe
de Vries, Ton
Bax, Jeroen J
Leon, Martin B
Van Mieghem, Nicolas M
Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title_full Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title_fullStr Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title_full_unstemmed Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title_short Aortic Stenosis and Heart Failure: Disease Ascertainment and Statistical Considerations for Clinical Trials
title_sort aortic stenosis and heart failure: disease ascertainment and statistical considerations for clinical trials
topic Co-Morbidities
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545996/
https://www.ncbi.nlm.nih.gov/pubmed/31179020
http://dx.doi.org/10.15420/cfr.2018.41.2
work_keys_str_mv AT spitzerernest aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT hahnrebeccat aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT pibarotphilippe aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT devrieston aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT baxjeroenj aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT leonmartinb aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials
AT vanmieghemnicolasm aorticstenosisandheartfailurediseaseascertainmentandstatisticalconsiderationsforclinicaltrials